Intergroup Trial C10403: A Pediatric Treatment Approach to Improve Outcomes in Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Abstract

Get full access to this article

View all access options for this article.

References

Smith

, Seibel

, Altekruse

et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol., 2010; 28:2625–2634.

Bleyer

. Older adolescents and young adults with acute lymphoblastic leukemia (ALL) in the United States: from the lowest to highest death rate and number of deaths—more rationale for the CALGB-SWOG-ECOG C10403 trial based on COG AALL0232. J Clin Oncol., 2008; 15Sabstract 18034.

American Cancer Society. Cancer facts & figures 2011. Atlanta: American Cancer Society, 2011.

Romana

, Poirel

, Leconiat

et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood., 1995; 86:4263–4269.

Moorman

, Ensor

, Richards

et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol., 2010; 11:429–438.

Heerema

, Sather

, Sensel

et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol., 1998; 16:1270–1278.

Larson

, Dodge

, Burns

et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood., 1995; 85:2025–2037.

Westbrook

, Hooberman

, Spino

et al.

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762)

Blood., 1992; 80:2983–2990.

Nachman

. Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia. Br J Haematol., 2005; 130:166–173.

10.

Sallan

. Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program., 2006; 2006:128–132.

11.

Bleyer

. Adolescent and young adult (AYA) oncology: the first A. Pediatr Hematol Oncol., 2007; 24:325–336.

12.

Stiller

, Benjamin

, Cartwright

et al. Patterns of care and survival for adolescents and young adults with acute leukemia—a population-based study. Br J Cancer., 1999; 79:658–665.

13.

Stock

, La

, Sanford

et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood., 2008; 112:1646–1654.

14.

Stock

. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program., 2010; 2010:21–29.

15.

Nachman

, La

, Hunger

et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the Children's Oncology Group. J Clin Oncol., 2009; 27:5189–5194.